8 Compared with placebo, once weekly tirzepatide significantly reduced the combined risk of cardiovascular death or worsening HF events (hospitalisation or an urgent hospital visit requiring intravenous therapy)
Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX, Smith LP, Cheng SS, Overdier KH, Thompson KR, Geraci MW, Douglas IS, Pearse DB, Tuder RM
Hence, early detection and consistent treatment can be a game-changer
Dual therapy in case of diabetes in the context of chronicle kidney disease (CKD) : Metformin + SGLT-2 inhibitor +/- DPP-4 inhibitor if needed
It helps regulate appetite and fullness, supports blood glucose balance, and plays a role in how your body uses energy
Chronic kidney disease (CKD) : Long-term loss of kidney function